Cooper Companies AI Adoption Tracker
Last updated: August 9, 2026
Overview
Cooper Companies is exploring artificial intelligence applications primarily through its CooperSurgical division, with the PGTaiSM technology platform launched in 2018 being its most significant AI initiative to date[1][2]. The company has also implemented an AI Acceptable Use policy in 2024 to guide responsible AI deployment across the business[3]. While Cooper Companies operates in the vision care and women's healthcare sectors where AI adoption is gaining traction, the company appears to be in early stages of AI integration compared to other medical device companies[4].
AI Maturity Index
Radar Comparison
Peer Comparison: Cooper Companies vs healthcare
Based on 66 companies in sector
| Dimension | Cooper Companies | Sector Avg | Diff |
|---|---|---|---|
| Adoption | 2.0 | 3.7 | -1.7 |
| Proficiency | 2.0 | 3.5 | -1.5 |
| Impact | 2.0 | 3.6 | -1.6 |
| Overall | 2.0 | 3.6 | -1.6 |
AI Hiring Signals
Cooper Companies Job Postings Analysis
Tech vs Non-Tech AI Requirements
Non-tech AI adoption exceeds tech roles - strong org-wide AI fluency signal
Top Departments by AI Mention Rate
Analysis
Cooper Companies shows moderate AI hiring emphasis at 9.6% overall, with an interesting pattern of non-tech roles (11.7%) having higher AI expectations than tech roles (4.3%). This suggests AI skills are being valued across business functions, particularly in customer service and legal departments.
View Sample Job Postings (8 sources)
Key Metrics
AI Initiatives
AI Acceptable Use Policy
2024
Company-wide policy to guide responsible use of AI systems across the business
Released as part of Cooper's focus on using artificial intelligence responsibly as AI adoption increases across various areas of the business
Frequently Asked Questions
Cooper's primary AI initiative is the PGTaiSM technology platform for genetic testing in fertility treatments, launched in 2018. The company has also implemented an AI Acceptable Use policy in 2024.
Cooper uses AI primarily in fertility and women's healthcare through its PGTaiSM platform, which improves genetic testing accuracy and removes human subjectivity in interpretation.
While Cooper has some AI applications, the company appears to be in early stages of AI adoption compared to other medical device companies, with most initiatives focused on its CooperSurgical division.
In Application
| Application | Vendor | Use Case |
|---|---|---|
| PGTaiSM Platform | CooperSurgical (internally developed) | Genetic testing interpretation and reporting for fertility treatments |
Sources
CooperSurgical, Inc. Launches PGTai Technology Platform and ERPeak Endometrial Receptivity Test
AI And Big Data Can Lead To Improved Outcomes In Fertility Care
2024 Cooper Companies Sustainability Report
Optical Gains Traction in Adopting Artificial Intelligence
Related Companies
About AI Tracker
AI Tracker is a research project by Larridin, the AI execution intelligence platform.
Methodology: We analyze earnings calls, press releases, partnership announcements, and product documentation. All assessments are based solely on publicly available information—no private customer data is used.
Maturity Scoring: Each dimension is rated on a 4-tier scale (Nascent → Emerging → Scaling → Leading) based on evidence from public sources. Industry averages are computed as the median across all tracked companies in the sector.